Meadowsweet (Filipendula ulmaria)

Filipendula ulmaria
Evidence Level
Preliminary
5 Clinical Trials
5 Documented Benefits
1/5 Evidence Score

Meadowsweet (Filipendula ulmaria) is a European wetland herb whose dried flowering tops are taken as a tea, powder or tincture. It contains small amounts of salicylate compounds (under 0.5% of the herb), flavonoids led by spiraeoside, and tannins such as rugosin D. The European Medicines Agency accepts meadowsweet only as a traditional herbal medicine, based on long-standing use with no supporting clinical data, for traditional uses that include relief of minor joint aches. The only controlled human study gave 20 healthy adults a drink combining meadowsweet, chamomile and willow bark and found no significant change in inflammation markers. The rest of the research is lab and rodent work. Because it contains salicylates, it is not for anyone with a salicylate or aspirin allergy, and the EU monograph does not recommend it under age 18 or in pregnancy.

Studied Dose No dose has been tested in a trial of meadowsweet alone. EU traditional-use monograph, adults: herb tea 1.5 to 6 g per cup (2 to 18 g a day); powdered herb 250 to 500 mg (up to 1,500 mg a day); 1:5 tincture 2 to 4 ml (6 to 12 ml a day). For joint use, no longer than 4 weeks.
Active Compound Salicylate compounds (mainly salicylaldehyde in the volatile oil and phenolic glycosides, under 0.5% of the herb), flavonoids led by spiraeoside (quercetin 4'-glucoside), and hydrolysable tannins such as rugosin D.

Benefits

Traditional European herbal tea for minor joint aches

The European Medicines Agency registers meadowsweet herb tea, powder and tincture as a traditional herbal medicine for minor joint aches. This status rests on at least 30 years of use, not on trials, and the agency's assessors found no clinical data supporting efficacy. The monograph limits this use to 4 weeks.

Inflammation markers in a three-herb drink study

In a 4-week randomized study, 20 healthy adults drank a berry-based beverage containing chamomile, meadowsweet and willow bark or the berry base alone. IL-1 beta fell about 22% on the herbal drink versus about 3% on the control, but no significant anti-inflammatory effect was found, and the study cannot separate meadowsweet from the other two herbs.

COX enzyme and cytokine activity in lab and rat studies

Lab and animal work only. A methanol extract of the aerial parts inhibited the COX-1 and COX-2 enzymes in a test tube (about 63% and 46% at 50 micrograms per ml) and reduced paw swelling in rats at 100 and 200 mg/kg. A water extract lowered IL-6 and TNF-alpha output from human immune cells grown in culture.

Pain sensitivity in a rat inflammation model

Animal work only. Freeze-dried meadowsweet flower tea given by mouth to rats at 100 to 300 mg/kg reduced sensitivity to pain in an inflamed paw in a dose-dependent way, with a half-maximal dose of about 165 mg/kg. It did not significantly reduce the swelling itself. No human pain study of meadowsweet alone exists.

Stomach lining in rodent studies

Animal work only. A flower decoction reduced stomach lesions caused by restraint, aspirin and other irritants in rats and mice and aided healing of alcohol-induced lesions, and freeze-dried flower tea given by mouth protected the rat stomach lining against alcohol. Yet the same decoction strengthened histamine's lesion-causing effect in guinea pigs, and EU assessors called the stomach findings contradictory.

Mechanism of action

1

Low salicylate content

Meadowsweet's salicylates are mostly salicylaldehyde and related glycosides that make up under 0.5% of the herb, compared with 0.5 to 10% in willow bark, according to the EU assessment. A cited pharmacology text describes water infusions as containing only trace salicylates. No study has measured salicylate levels in human blood after meadowsweet.

2

Flavonoids led by spiraeoside

The flowering herb contains about 3 to 4% flavonoids, mainly spiraeoside. Freeze-dried flower tea contained about 56 mg of spiraeoside per gram. In lab tests, spiraeoside scavenged free radicals and blocked formation of an inflammatory lipid (12(S)-HETE) in human platelets; at 50 mg/kg by mouth it also protected the rat stomach lining.

3

Ellagitannins and gut bacteria

Meadowsweet tannins such as rugosin D and tellimagrandin II blocked the histamine-making enzyme histidine decarboxylase in a test tube. When a water extract of the herb was incubated with human stool bacteria, the bacteria turned its tannins into urolithins, compounds that reduced TNF-alpha from cultured immune cells. Neither effect has been shown in people taking meadowsweet.

Clinical trials

1
Chamomile, Meadowsweet and Willow Bark Beverage: 4-Week Randomized Study in Healthy Adults
PubMed

Randomized, controlled 4-week study of a functional beverage combining three herbs in a berry extract base, with the berry extract alone as the control; the abstract does not state blinding or herb amounts. (Drummond et al. 2013, J Diet Suppl)

20 healthy adults, not selected for raised inflammation.

Serum IL-1 beta fell about 22% on the herbal drink and about 3% on the control, but the authors report no significant anti-inflammatory effect and call the evidence inconclusive. A subgroup analysis by baseline TNF-alpha showed lower IL-6 and some reported joint function improvement, without significance reported in the abstract. Meadowsweet was one of three herbs, so its own effect cannot be isolated.

2
Meadowsweet Extracts and COX Enzymes, Pain and Paw Swelling (lab and rat study)
PubMed

In vitro enzyme and cell tests plus rat hot plate and carrageenan paw edema tests of methanol extracts of the aerial parts and the roots, with indomethacin as comparator. (Katanić et al. 2016, J Ethnopharmacol)

Rats given 100 or 200 mg/kg of extract; THP-1 human immune cells and isolated COX enzymes in vitro.

At 50 micrograms per ml the aerial-part extract inhibited COX-1 by about 63% and COX-2 by about 46%, roughly twice the root extract, but it cut COX-2 gene expression in cells by only about 10%. Both extracts lengthened hot plate latency (p<0.05) and the aerial-part extract reduced paw swelling at both doses. Animal and lab results only.

3
Meadowsweet Flower Tea and Inflammatory Pain Sensitivity (rat study)
PubMed

Animal study of freeze-dried flower infusions of meadowsweet and dropwort given by mouth in the carrageenan paw model, with an acute toxicity test in mice. (Samardžić et al. 2016, J Ethnopharmacol)

Rats with carrageenan-induced paw inflammation given 100 to 300 mg/kg by mouth; mice for toxicity.

Meadowsweet tea reduced pain hypersensitivity in a dose-dependent way (ED50 about 165 mg/kg) but did not significantly reduce paw swelling. Spiraeoside was the main compound at about 56 mg/g. In mice the estimated lethal dose was likely above 2,000 mg/kg, with animals observed for 14 days. Animal results only.

4
Meadowsweet Flower Tea, Spiraeoside and the Stomach Lining (lab and rat study)
PubMed

Antioxidant and anti-inflammatory lab assays and a rat alcohol-induced stomach injury model of freeze-dried flower infusions and isolated compounds. (Samardžić et al. 2018, J Ethnopharmacol)

Rats given freeze-dried meadowsweet or dropwort flower tea at 100 to 300 mg/kg by mouth, spiraeoside at 50 mg/kg or tellimagrandin II at 40 mg/kg (both compounds isolated from dropwort); human platelets and chemical assays in vitro.

The flower teas matched the positive control in two antioxidant assays and protected the rat stomach lining against alcohol, as did spiraeoside and tellimagrandin II. Spiraeoside blocked 12(S)-HETE formation in human platelets (IC50 about 4.7 micrograms per ml). The abstract gives no p values. Animal and lab results only.

5
Severe Bleeding in a Child Taking a Meadowsweet and Willow Herbal Syrup (case report)
PubMed

Case report from the Italian herbal surveillance system of serious gastrointestinal bleeding after a multi-herb syrup. (Moro et al. 2011, Ann Ist Super Sanita)

A previously healthy 4-year-old boy given a multi-herb syrup containing Filipendula ulmaria and willow (Salix) for a mild cold with fever.

The boy developed shock from severe gastrointestinal bleeding; testing confirmed salicylates in the syrup, and the authors rated the link to the syrup as probable. He recovered after intensive care and the product was withdrawn from the Italian market. A single case with two salicylate herbs, so meadowsweet alone cannot be blamed.

Side effects and drug interactions

Common Potential side effects

The EU monograph lists no known side effects, but its assessors note that human safety data are very limited and that no clinical safety studies exist.
Contraindicated in people with salicylate hypersensitivity, which includes aspirin allergy, according to the EU monograph.
Not recommended for children and adolescents under 18 because of a lack of data. In one Italian case, a 4-year-old developed severe stomach bleeding after a multi-herb syrup containing meadowsweet and willow (Salix).
Not recommended in pregnancy or breastfeeding, because safety has not been established.
Standard genotoxicity, reproductive and cancer-risk testing has not been done. A methanol extract increased DNA damage in the comet assay on human white blood cells but was negative in the Ames test; EU assessors judged these methods insufficient to draw conclusions.
In animal studies, flower preparations increased airway tone in cats and strengthened histamine-induced airway narrowing in guinea pigs; the relevance to people with asthma is unknown.

Important Drug interactions

Aspirin, other salicylates and NSAIDs (ibuprofen, naproxen): the EU monograph advises against combining them with meadowsweet without medical advice.
Warfarin, other anticoagulants and antiplatelet drugs: no interactions have been documented and the salicylate dose is low, but flower extracts showed anticoagulant activity in animal studies, so ask a clinician before combining.
Products that also contain willow bark or other salicylate herbs add to the total salicylate intake.

Frequently asked questions about Meadowsweet (Filipendula ulmaria)

Is meadowsweet the same as aspirin or willow bark?

No. Meadowsweet contains salicylate compounds, the same chemical family as aspirin, but at under 0.5% of the herb, lower than willow bark, and tea made from it is described as containing only trace amounts. No study has measured how much salicylate reaches the blood after drinking it. It should still be avoided by anyone told to avoid aspirin.

Has meadowsweet been tested in people?

Barely. EU regulators found no clinical trials supporting its traditional uses. The only controlled human study gave 20 healthy adults a drink combining meadowsweet, chamomile and willow bark for 4 weeks and found no significant change in inflammation markers. The rest of the research is in cells and rodents.

How is meadowsweet usually taken?

Most often as a tea. The EU traditional-use monograph lists 1.5 to 6 g of dried herb per cup, up to 18 g a day, for adults, or 250 to 500 mg of powdered herb up to 1,500 mg a day, or 2 to 4 ml of a 1:5 tincture up to 12 ml a day. For joint use it advises no more than 4 weeks.

Who should avoid meadowsweet?

Anyone with a salicylate or aspirin allergy, children and teenagers under 18, and people who are pregnant or breastfeeding, per the EU monograph. People taking aspirin, NSAIDs, blood thinners or antiplatelet drugs should ask a clinician first. In one reported case a young child had severe stomach bleeding after a multi-herb syrup that combined meadowsweet with willow (Salix).

What is Meadowsweet?

Meadowsweet (Filipendula ulmaria) is a European wetland herb whose dried flowering tops are taken as a tea, powder or tincture. It contains small amounts of salicylate compounds (under 0.5% of the herb), flavonoids led by spiraeoside, and tannins such as rugosin D.

What is Meadowsweet used for?

Meadowsweet has several researched uses. The European Medicines Agency registers meadowsweet herb tea, powder and tincture as a traditional herbal medicine for minor joint aches.

What is the recommended dosage of Meadowsweet?

The clinically studied dose is No dose has been tested in a trial of meadowsweet alone. EU traditional-use monograph, adults: herb tea 1.5 to 6 g per cup (2 to 18 g a day); powdered herb 250 to 500 mg (up to 1,500 mg a day); 1:5 tincture 2 to 4 ml (6 to 12 ml a day). Always follow the product label and check with a healthcare provider for personal advice.

Is Meadowsweet safe, and does it have side effects?

Side effects and cautions reported for Meadowsweet include: The EU monograph lists no known side effects, but its assessors note that human safety data are very limited and that no clinical safety studies exist. Contraindicated in people with salicylate hypersensitivity, which includes aspirin allergy, according to the EU monograph. It may also interact with some medications. Meadowsweet is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Meadowsweet interact with any medications?

Possible interactions include: Aspirin, other salicylates and NSAIDs (ibuprofen, naproxen): the EU monograph advises against combining them with meadowsweet without medical advice. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Meadowsweet?

NutraSmarts rates the evidence for Meadowsweet as Preliminary (1 out of 5). It is backed by 5 clinical trials and 14 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(14 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Filipendula ulmaria (L.) Maxim., herba. EMA/HMPC/434881/2010. European Medicines Agency. 2011;Final, adopted 12 July 2011. EMA/HMPC/434881/2010..SourceUsed to support: Not PubMed-indexed; EU regulatory monograph. Accepts meadowsweet herb as a traditional herbal medicine, based exclusively on long-standing use, for supportive treatment of the common cold and relief of minor joint pain. Adult doses: tea 1.5 to 6 g per dose (2 to 18 g a day), powder 250 to 500 mg (250 to 1,500 mg a day), 1:5 tincture 2 to 4 ml (6 to 12 ml a day, joint use only), no more than 4 weeks for joint use. Contraindicated in salicylate hypersensitivity; not recommended under 18 or in pregnancy and lactation; combining with salicylates and other NSAIDs not recommended without medical advice; no interactions or undesirable effects known; genotoxicity, carcinogenicity and reproductive toxicity not tested.
  2. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment report on Filipendula ulmaria (L.) Maxim., herba and Filipendula ulmaria (L.) Maxim., flos. EMA/HMPC/434892/2010. European Medicines Agency. 2011;Final, 12 July 2011. EMA/HMPC/434892/2010..SourceUsed to support: Not PubMed-indexed; EU regulatory assessment. Constituents: salicylates under 0.5%, mostly as glycosides and salicylaldehyde in the volatile oil; flavonoids 3 to 4% in the flowering herb (mainly spiraeoside); hydrolysable tannins 1 to 12% (mainly rugosin D). Cites a pharmacology text describing infusions as containing only trace salicylates, versus 0.5 to 10% salicylates in willow bark. Finds no human pharmacokinetic or pharmacodynamic data and no clinical data supporting efficacy for joint pain or colds; the only clinical report was topical use of a flower ointment. Notes animal findings of contradictory stomach effects, increased bronchial tone and histamine-induced bronchospasm, and anticoagulant activity of an injected flower extract.
  3. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Addendum to Assessment report on Filipendula ulmaria (L.) Maxim. (= Spiraea ulmaria L.), herba. EMA/HMPC/595722/2019. European Medicines Agency. 2020;Adopted 6 May 2020. EMA/HMPC/595722/2019..SourceUsed to support: Not PubMed-indexed; EU periodic review covering 2011 to 2018. Of the anti-inflammatory references found, only one was a clinical study (the three-herb beverage trial), which tested meadowsweet only in combination and was inconclusive. Two genotoxicity studies of methanol extracts were judged insufficient because of the solvent and methodological shortcomings. EudraVigilance held 6 cases, all with meadowsweet combined with other herbs and drugs. The committee decided no revision of the monograph was needed.
  4. Drummond EM, Harbourne N, Marete E, Jacquier JC, O'Riordan D, Gibney ER. An in vivo study examining the antiinflammatory effects of chamomile, meadowsweet, and willow bark in a novel functional beverage. J Diet Suppl. 2013;10(4):370-80. doi: 10.3109/19390211.2013.830680.PubMedUsed to support: Randomized 4-week study in 20 healthy adults of a beverage combining chamomile, meadowsweet and willow bark in a berry extract base, with the berry extract as control. IL-1 beta fell about 22% on the herbal drink and about 3% on control, but no significant anti-inflammatory effects were seen and the authors call the evidence inconclusive. The only controlled human study involving meadowsweet, and it cannot isolate meadowsweet's effect.
  5. Drummond EM, Harbourne N, Marete E, Martyn D, Jacquier J, O'Riordan D, Gibney ER. Inhibition of proinflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark. Phytother Res. 2013;27(4):588-94. doi: 10.1002/ptr.4753.PubMedUsed to support: Cell culture study in THP-1 human macrophages: aqueous extracts of willow bark, meadowsweet and chamomile reduced IL-6 and TNF-alpha production, with willow bark most active, then meadowsweet, then chamomile. Lab work only.
  6. Katanić J, Boroja T, Mihailović V, Nikles S, Pan SP, Rosić G, Selaković D, Joksimović J, Mitrović S, Bauer R. In vitro and in vivo assessment of meadowsweet (Filipendula ulmaria) as anti-inflammatory agent. J Ethnopharmacol. 2016;193:627-636. doi: 10.1016/j.jep.2016.10.015.PubMedUsed to support: Methanol extracts of meadowsweet aerial parts inhibited COX-1 (about 63%) and COX-2 (about 46%) at 50 micrograms per ml, about twice the root extract, but reduced COX-2 gene expression in THP-1 cells by only about 10%. In rats at 100 and 200 mg/kg, both extracts lengthened hot plate latency and the aerial-part extract reduced carrageenan paw swelling. Lab and animal work only.
  7. Samardžić S, Tomić M, Pecikoza U, Stepanović-Petrović R, Maksimović Z. Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation. J Ethnopharmacol. 2016;193:652-656. doi: 10.1016/j.jep.2016.10.024.PubMedUsed to support: Freeze-dried flower infusions given by mouth to rats at 100 to 300 mg/kg reduced carrageenan-induced pain hypersensitivity dose-dependently (meadowsweet ED50 about 165 mg/kg) without significantly reducing swelling. Spiraeoside was the main compound (about 56 mg/g). Acute oral LD50 in mice was likely above 2,000 mg/kg. Animal work only.
  8. Samardžić S, Arsenijević J, Božić D, Milenković M, Tešević V, Maksimović Z. Antioxidant, anti-inflammatory and gastroprotective activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench. J Ethnopharmacol. 2018;213:132-137. doi: 10.1016/j.jep.2017.11.013.PubMedUsed to support: Freeze-dried meadowsweet and dropwort flower infusions matched the positive control in DPPH and FRAP antioxidant assays and, at 100 to 300 mg/kg by mouth, protected the rat stomach against alcohol-induced injury; spiraeoside (50 mg/kg) and tellimagrandin II (40 mg/kg), both isolated from dropwort, also protected against lesions. Spiraeoside inhibited 12(S)-HETE formation in human platelets (IC50 4.69 micrograms per ml). Lab and animal work only.
  9. Barnaulov OD, Denisenko PP. [Anti-ulcer action of a decoction of the flowers of the dropwort, Filipendula ulmaria (L.) Maxim]. Farmakol Toksikol. 1980;43(6):700-5.PubMedUsed to support: Russian-language rodent study (English abstract): a 1:10 and 1:20 flower decoction reduced stomach lesions from restraint, pylorus ligation, reserpine, phenylbutazone and acetylsalicylic acid in rats and mice and aided healing of alcohol-induced chronic lesions in rats, but did not protect against cinchophen and increased the ulcer-causing and bronchospastic effects of histamine in guinea pigs. Animal work only.
  10. Moro PA, Flacco V, Cassetti F, Clementi V, Colombo ML, Chiesa GM, Menniti-Ippolito F, Raschetti R, Santuccio C. Hypovolemic shock due to severe gastrointestinal bleeding in a child taking an herbal syrup. Ann Ist Super Sanita. 2011;47(3):278-83. doi: 10.4415/ANN_11_03_07.PubMedUsed to support: Case report of a previously healthy 4-year-old boy who developed hypovolemic shock from severe gastrointestinal bleeding after a multi-herb syrup containing Filipendula ulmaria and Salix (willow) given for a mild cold with fever. Salicylates were confirmed in the syrup and the Naranjo assessment rated the association probable; the product was withdrawn from the Italian market. A single case with two salicylate-containing herbs.
  11. Pukalskienė M, Slapšytė G, Dedonytė V, Lazutka JR, Mierauskienė J, Venskutonis PR. Genotoxicity and antioxidant activity of five Agrimonia and Filipendula species plant extracts evaluated by comet and micronucleus assays in human lymphocytes and Ames Salmonella/microsome test. Food Chem Toxicol. 2018;113:303-313. doi: 10.1016/j.fct.2017.12.031.PubMedUsed to support: Lab study of methanol extracts of five Agrimonia and Filipendula species including meadowsweet: strong antioxidant activity; increased DNA damage in the comet assay in human lymphocytes, but no mutations in the Ames test and no chromosome damage in the micronucleus test, with a slight fall in the nuclear division index. EU assessors later judged the methods insufficient to change the monograph.
  12. Piwowarski JP, Granica S, Zwierzyńska M, Stefańska J, Schopohl P, Melzig MF, Kiss AK. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials. J Ethnopharmacol. 2014;155(1):801-9. doi: 10.1016/j.jep.2014.06.032.PubMedUsed to support: Ex vivo study: aqueous extracts of ellagitannin-rich plants, including meadowsweet herb, were incubated with human fecal bacteria, which produced urolithins. The urolithins reduced TNF-alpha production by stimulated THP-1 macrophages (urolithin A most potent). The plant extracts themselves were not tested in people.
  13. Nitta Y, Kikuzaki H, Azuma T, Ye Y, Sakaue M, Higuchi Y, Komori H, Ueno H. Inhibitory activity of Filipendula ulmaria constituents on recombinant human histidine decarboxylase. Food Chem. 2013;138(2-3):1551-6. doi: 10.1016/j.foodchem.2012.10.074.PubMedUsed to support: Enzyme study: four ellagitannins isolated from meadowsweet petals (rugosin D, rugosin A, rugosin A methyl ester and tellimagrandin II) were non-competitive inhibitors of recombinant human histidine decarboxylase, the enzyme that makes histamine, with Ki values of about 0.35 to 1 micromolar. Test-tube work only.
  14. Liapina LA, Koval'chuk GA. [A comparative study of the action on the hemostatic system of extracts from the flowers and seeds of the meadowsweet (Filipendula ulmaria (L.) Maxim.)]. Izv Akad Nauk Ser Biol. 1993;(4):625-8.PubMedUsed to support: Russian-language study (English abstract): extracts of meadowsweet flowers and seeds showed high anticoagulant activity in vitro and, when given orally in experimental animals, had anticoagulant and fibrinolytic effects. Doses are not given in the abstract. Animal and lab work only; no human data.